// App-Quantinova.ai

275 : The role of interleukin 3 (IL3) in allergic asthma

Researchers

Presenter

  • Klle J

Principal Investigators

  • Vuorinen T

  • Kiefer A

  • Zimmermann T

  • Xepapadaki P

  • Rieker R

  • Papadopoulos NG

  • Finotto S

Medical Centers

  • Department of Dermatology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany

  • Department of Pathology, University of Turku, Turku, Finland

  • Department of Dermatology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany

  • National and Kapodistrian University of Athens, 2nd Pediatric Clinic, Allergy and Clinical Immunology Unit, Athens, Greece

  • Department of Dermatology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany

  • Centre for Respiratory Medicine & Allergy, Division of Infection, Immunity & Respiratory Medicine, University of Manchester, Manchester, United Kingdom

Locations

  • Germany

  • Finland

  • Greece

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • Interleukin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved